HOME >> BIOLOGY >> NEWS
New gene monitors cell division, cancer clinical applications seen

In health, most cells undergo a carefully orchestrated cell-division process in order to replicate. At the heart of this process is mitosis, in which a cell's nucleus duplicates its genetic material and divides. Precisely controlled mitosis is vital to survival, and rigorous checkpoint mechanisms are in place to ensure that each step in the process is properly executed before the cell moves on to the next step. Although not well proven, it is generally believed that many human cancers stem from checkpoint defects in mitosis.

In the July 27 issue of Nature, scientists at The Wistar Institute report identification of a new gene called chfr that establishes a previously unknown checkpoint in mitosis. Further, a laboratory survey of eight human cancer cell lines found chfr to be inactivated, through lack of expression or mutation, in four of the eight -- fully half of the cell lines studied. Mitotic checkpoint genes identified in earlier studies had been linked to cancers, too, but mutant versions had been found in only 1 or 2 percent of cancers.

"The frequency of mutations in previously identified mitotic checkpoint genes is too low to explain the incidence rates of cancers in which troubled cell division is thought to play a role," says Thanos D. Halazonetis, D.D.S., Ph.D., senior author on the study and an associate professor at Wistar. "So, the question was whether there were checkpoint genes we didn't know about and whether those were the genes suffering mutations in these cancers. What we found was a new gene and a wholly new mechanism that monitors progress through mitosis. Further, this gene was disrupted in 50 percent of the cancer cell lines we studied, much higher than the rates for other known checkpoint genes."

Halazonetis emphasizes that studies of tumors from patients will be needed to confirm that mutant chfr is as common in primary cancer cells as it is in laboratory cancer cell lines. If the findings are confirmed, however, clinical a
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
26-Jul-2000


Page: 1 2

Related biology news :

1. Imaging technique discovered at Stanford monitors cancer cell proliferation
2. Researchers call for trials of menstrual cycle monitors used for natural family planning
3. Newer design of close-up computer monitors increases ease of use
4. New technique monitors chromium contamination in groundwater
5. MIT instrument monitors molten materials
6. Researchers link failed cell division, Alzheimers disease
7. Leader in cancer treatment and prevention research honored
8. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
9. Chemical derived from vitamin-E shows early promise as cancer drug
10. New molecular link key to cellular proteins involved in cancer progression, other diseases
11. Phase II trials of second-generation antisense cancer drug planned following successful early study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics ... a solution that uniquely combines lab testing insights and hc1’s exclusive Local Risk ... ongoing health and safety of employees returning to the workplace. , “Some of ...
(Date:5/21/2020)... ALPHARETTA, Ga. (PRWEB) , ... ... ... provider of Human Capital IntegritySM technology-based services specializing in background and medical ... with their COVID-19 return-to-work planning and keeping their workforce safe. The new ...
(Date:5/15/2020)... ... May 15, 2020 , ... The National Institutes of Health ... firm based in Frederick, Maryland and Tysons Corner, Virginia, to provide patent legal services ... a another in the field of chemistry. The firm is one of nine firms ...
Breaking Biology News(10 mins):
(Date:5/28/2020)... ... 2020 , ... Genedata, the leading provider of enterprise software ... 17.0, the latest version of its enterprise software for the automated analysis, visualization, ... host a webinar on June 10, 2020, detailing and demonstrating the features and ...
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast of ... strategy and M&A advisory firm. , This is an important step for Eaton Square ... healthcare innovators with capital and investors. , Popper and Company, founded in 2003 by ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a ... Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board ... as work closely with CEO Brian Miller and Sentien’s management team. , ...
(Date:5/9/2020)... ... May 08, 2020 , ... Worldwide Business with ... successful business program on Sunday, May 10, 2020 and Wednesday, May 13, 2020 at ... episode’s exclusive interviews will spotlight key executives from Techolution and Bravado ...
Breaking Biology Technology:
Cached News: